Bleeding and thrombotic problems in a patient with alpha2 plasmin inhibitor deficiency [8]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 2, 2005, Pages 399-401

  Hayward, Catherine P M ^b,c   Cina C S ^a   Staunton, M ^a   Jurriaans, E ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 7A; CLOPIDOGREL; HEPARIN; TRANEXAMIC ACID; ANTIPLASMIN;

ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; AORTA GRAFT; AORTA SURGERY; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; FIBRINOLYSIS; HEMATOMA; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; SYMPTOMATOLOGY; THROMBOSIS; AGING; FATALITY; MIDDLE AGED;

AGING; ANTIPLASMIN; FATAL OUTCOME; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; THROMBOSIS;

EID: 20844460635     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01114.x     Document Type: Letter

References (5)

1. Saito H. Alpha 2-plasmin inhibitor and its deficiency states. J Lab Clin Med 1988; 112: 671-8.
2. Favier R, Aoki N, de Moerloose P. Congenital α2-antiplasmin inhibitor deficiencies: a review. Br J Haematol 2001; 114: 4-10.
3. Hanss MM, Farcis M, Ffrench PO, de Manzancourt P, Dechavanne M. A splicing donor site point mutation in intron 6 of the plasmin inhibitor (alpha2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency. Blood Coagul Fibrinol 2003; 14: 107-11.
4. Hedner U, Hirsh J, Marder VJ. Therapy with antifibrinolytic agents. In: Colman, RW, Hirsh, J, Marder, VJ, Clowees, AW, George, JN, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001: 795-7.
5. McKay H, Derome F, Haq MA, Whittaker S, Arnold E, Adam F, Heddle NM, Rivard GE, Hayward CPM. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004; 104: 159-65.